Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2007, p. 794-795, Vol. 51, No. 2
0066-4804/07/$08.00+0 doi:10.1128/AAC.01145-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205
Received 12 September 2006/ Returned for modification 27 October 2006/ Accepted 22 November 2006
Salicylate has previously been shown to reduce the susceptibility of Mycobacterium tuberculosis to several drugs in vitro. In this study, aspirin, a salicylate anti-inflammatory, antagonized isoniazid treatment of murine pulmonary tuberculosis, whereas the nonsalicylate ibuprofen did not. These results may have implications on concurrent administration of anti-inflammatory and antituberculosis drugs.
Published ahead of print on 4 December 2006.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»